Streetbeat News

Analyst Ratings

NSA

Wells Fargo analyst Todd Stender has maintained an Underweight rating on National Storage (NYSE:NSA) and lowered the price target from $34 to $32.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:18 pm

AMZN

Seaport Global analyst Aaron Kessler has initiated coverage on Amazon.com (NASDAQ:AMZN) with a Buy rating and a price target of $145.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:17 pm

MATX

Wolfe Research analyst Scott Group has maintained an 'Outperform' rating on Matson (NYSE:MATX) and raised the price target from $113 to $116.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:16 pm

LCTX

Lineage Cell Therapeutics, Inc. (LCTX) announced that its CEO, Brian M. Culley, will present at the 'Mapping the Future of Geographic Atrophy' session at Eyecelerator 2023. The session will also feature executives from Apellis Pharmaceuticals, Iveric Bio, Annexon Biosciences, Aviceda Therapeutics, and ONL Therapeutics. Additionally, results from a Phase 1/2a clinical study of RG6501 (OpRegen) will be presented, showing evidence of rapid improvement in outer retinal structure and continued clinical benefit. RG6501 is being developed under a collaboration between Lineage, Roche, and Genentech.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:16 pm

ABNB

Seaport Global analyst Aaron Kessler has initiated coverage on Airbnb (NASDAQ:ABNB) with a Neutral rating.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:15 pm

SWIM

Latham Group, Inc. (NASDAQ:SWIM) has announced the appointment of Oliver Gloe as Chief Financial Officer (CFO), effective November 13, 2023. Gloe, who has over 20 years of experience leading finance teams within global manufacturing companies, will join Latham on October 30, 2023 as Vice President, Finance before assuming the CFO role. He will oversee Latham's finance, strategic planning, investor relations, treasury, tax and accounting reporting functions and report to Latham President and CEO, Scott Rajeski.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:15 pm

DX

JonesTrading analyst Jason Stewart maintains a 'Buy' rating on Dynex Capital (NYSE:DX) but has lowered the price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:14 pm

FHTX

Foghorn Therapeutics Inc. (NASDAQ:FHTX) will present new data from multiple preclinical and clinical programs at the 6th Annual Targeted Protein Degradation (TPD) Summit and the Connective Tissue Oncology Society (CTOS) Annual Meeting. The company will present data from its selective EP300 and CBP degrader programs, and preliminary results from a Phase 1 study of FHD-609, a bromodomain-containing protein 9 degrader.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:14 pm

OKTA

Jefferies analyst Joseph Gallo maintains a 'Buy' rating on Okta (NASDAQ:OKTA) but has lowered the price target from $105 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:09 pm

BBIO

Analysts have provided bullish ratings for BridgeBio Pharma (NASDAQ:BBIO) in the last quarter. In the last 3 months, 4 analysts have offered 12-month price targets for BridgeBio Pharma with an average price target of $52.0, an increase of 13.04% from the previous average price target of $46.00.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 12:01 pm